EBE webinar on French biosimilars law

27 Feb 2014

EBE training, 6th of February:

EBE held a webinar in cooperation with LEEM (the French pharmaceutical organisation, representing +270 members). The theme was the recently adopted French biosimilars law, which contains provisions to permit a restricted form of pharmacy-level “substitution” for similar biological medicines, i.e. limited to those patients who are initiating treatment. Chair of the Biosimilars task-force, Alexander Roediger (MSD), and Andrew Bruce, Topic Group Leader (Amgen), lead the webinar where representatives from LEEM explained the developments, its implications, and next steps. EBE will follow the ongoing work on implementation and plans another update in the next two months.